AT-60A RANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED PHASE 2 TRIAL OF DENDRITIC CELL (DC) VACCINE ICT-107 FOLLOWING STANDARD TREATMENT IN NEWLY DIAGNOSED PATIENTS WITH GBM
暂无分享,去创建一个
P. Wen | W. Curry | J. Landolfi | S. Kesari | K. Fink | Jay-Jiguang Zhu | S. Phuphanich | D. O’Rourke | D. Reardon | J. Markert | G. Lesser | E. Pan | M. Gruber | M. Glantz | D. Peereboom | John S. Yu | L. Kim | R. Aiken | R. Larocca